Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide

被引：0
作者：
Sandra Coral
Giulia Parisi
Hugues J. M. G. Nicolay
Francesca Colizzi
Riccardo Danielli
Elisabetta Fratta
Alessia Covre
Pietro Taverna
Luca Sigalotti
Michele Maio
机构：
[1] Centro di Riferimento Oncologico,Cancer Bioimmunotherapy Unit
[2] Istituto Toscano Tumori,Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena
[3] Astex Pharmaceuticals,undefined
[4] Inc.,undefined
来源：
Cancer Immunology, Immunotherapy | 2013年 / 62卷
关键词：
DNA hypomethylating agent; Cancer; Immunotherapy; Epigenetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：605 / 614
页数：9
相关论文
共 50 条
  • [41] Effect of trichostatin A and 5-Aza-2′-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells
    Kong, Qingran
    Wu, Meiling
    Wang, Zhenkun
    Zhang, Xinmiao
    Li, Lu
    Liu, Xiangyu
    Mu, Yanshuang
    Liu, Zhonghua
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 355 (1-2) : 157 - 165
  • [42] Genome-Wide Demethylation by 5-aza-2’-Deoxycytidine Alters the Cell Fate of Stem/Progenitor Cells
    Yang Zhou
    Zhengqing Hu
    Stem Cell Reviews and Reports, 2015, 11 : 87 - 95
  • [43] 5-Aza-2′-deoxycytidine inhibits retinoblastoma cell by reactivating epigenetically silenced RASSF1Agene
    Liu, Ru
    Zhang, Xiao-Huan
    Zhang, Kun
    Li, Wei
    Wang, Wen-Jun
    Luo, Di-Xian
    Gao, Ling
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (01) : 51 - 56
  • [44] Epigenetic therapy of non-small cell ung cancer using decitabine (5-aza-2'-deoxycytidine)
    Momparler, Richard L.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [45] 5-Aza-2′-deoxycytidine Induced Growth Inhibition of Leukemia Cells through Modulating Endogenous Cholesterol Biosynthesis
    Zhang, Fan
    Dai, Xiaoxia
    Wang, Yinsheng
    MOLECULAR & CELLULAR PROTEOMICS, 2012, 11 (07)
  • [46] The epigenetic modifiers 5-aza-2′-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells
    Zych, J.
    Stimamiglio, M. A.
    Senegaglia, A. C.
    Brofman, P. R. S.
    Dallagiovanna, B.
    Goldenberg, S.
    Correa, A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2013, 46 (05) : 405 - 416
  • [47] 5-Aza-2'-deoxycytidine induces a greater inflammatory change, at the molecular levels, in normoxic than hypoxic tumor microenvironment
    de Amorim, Isis Salviano Soares
    Rodrigues, Juliana Alves
    Nicolau, Pedro
    Konig, Sandra
    Panis, Carolina
    da Fonseca, Adenilson de Souza
    Mencalha, Andre Luiz
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (02) : 1161 - 1169
  • [48] Effects of Treatment with the Hypomethylating Agent 5-aza-2′-deoxycytidine in Murine Type II Collagen-Induced Arthritis
    Petralia, Maria Cristina
    Mazzon, Emanuela
    Basile, Maria Sofia
    Cutuli, Marco
    Di Marco, Roberto
    Scandurra, Fabiola
    Saraceno, Andrea
    Fagone, Paolo
    Nicoletti, Ferdinando
    Mangano, Katia
    PHARMACEUTICALS, 2019, 12 (04)
  • [49] Pharmacokinetic and pharmacodynamic analysis of 5-aza-2′-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
    Karahoca, Metin
    Momparler, Richard L.
    CLINICAL EPIGENETICS, 2013, 5
  • [50] Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
    Metin Karahoca
    Richard L Momparler
    Clinical Epigenetics, 2013, 5
12345